Johnson & Johnson will go head-to-head in the US neurovascular market against Medtronic PLC and Stryker Corp. with its EmboTrap clot retrieval device, after US FDA gave the product the thumbs-up.
The device, which is already CE-marked, received 510(k) clearance on May 9. It will be commercialized by J&J's Cerenovus division...